Global Toxicology Drug Screening Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Toxicology Drug Screening Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Cardiovascular Disease Drug Screening
  • 1.2.3 Obesity Drug Screening
  • 1.2.4 Diabetes Drug Screening
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Toxicology Drug Screening Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Laboratory
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Toxicology Drug Screening Market Perspective (2017-2028)
• 2.2 Toxicology Drug Screening Growth Trends by Region
  • 2.2.1 Toxicology Drug Screening Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Toxicology Drug Screening Historic Market Size by Region (2017-2022)
  • 2.2.3 Toxicology Drug Screening Forecasted Market Size by Region (2023-2028)
• 2.3 Toxicology Drug Screening Market Dynamics
  • 2.3.1 Toxicology Drug Screening Industry Trends
  • 2.3.2 Toxicology Drug Screening Market Drivers
  • 2.3.3 Toxicology Drug Screening Market Challenges
  • 2.3.4 Toxicology Drug Screening Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Toxicology Drug Screening Players by Revenue
  • 3.1.1 Global Top Toxicology Drug Screening Players by Revenue (2017-2022)
  • 3.1.2 Global Toxicology Drug Screening Revenue Market Share by Players (2017-2022)
• 3.2 Global Toxicology Drug Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Toxicology Drug Screening Revenue
• 3.4 Global Toxicology Drug Screening Market Concentration Ratio
  • 3.4.1 Global Toxicology Drug Screening Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Toxicology Drug Screening Revenue in 2021
• 3.5 Toxicology Drug Screening Key Players Head office and Area Served
• 3.6 Key Players Toxicology Drug Screening Product Solution and Service
• 3.7 Date of Enter into Toxicology Drug Screening Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Toxicology Drug Screening Breakdown Data by Type

• 4.1 Global Toxicology Drug Screening Historic Market Size by Type (2017-2022)
• 4.2 Global Toxicology Drug Screening Forecasted Market Size by Type (2023-2028)

5 Toxicology Drug Screening Breakdown Data by Application

• 5.1 Global Toxicology Drug Screening Historic Market Size by Application (2017-2022)
• 5.2 Global Toxicology Drug Screening Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Toxicology Drug Screening Market Size (2017-2028)
• 6.2 North America Toxicology Drug Screening Market Size by Type
  • 6.2.1 North America Toxicology Drug Screening Market Size by Type (2017-2022)
  • 6.2.2 North America Toxicology Drug Screening Market Size by Type (2023-2028)
  • 6.2.3 North America Toxicology Drug Screening Market Share by Type (2017-2028)
• 6.3 North America Toxicology Drug Screening Market Size by Application
  • 6.3.1 North America Toxicology Drug Screening Market Size by Application (2017-2022)
  • 6.3.2 North America Toxicology Drug Screening Market Size by Application (2023-2028)
  • 6.3.3 North America Toxicology Drug Screening Market Share by Application (2017-2028)
• 6.4 North America Toxicology Drug Screening Market Size by Country
  • 6.4.1 North America Toxicology Drug Screening Market Size by Country (2017-2022)
  • 6.4.2 North America Toxicology Drug Screening Market Size by Country (2023-2028)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Toxicology Drug Screening Market Size (2017-2028)
• 7.2 Europe Toxicology Drug Screening Market Size by Type
  • 7.2.1 Europe Toxicology Drug Screening Market Size by Type (2017-2022)
  • 7.2.2 Europe Toxicology Drug Screening Market Size by Type (2023-2028)
  • 7.2.3 Europe Toxicology Drug Screening Market Share by Type (2017-2028)
• 7.3 Europe Toxicology Drug Screening Market Size by Application
  • 7.3.1 Europe Toxicology Drug Screening Market Size by Application (2017-2022)
  • 7.3.2 Europe Toxicology Drug Screening Market Size by Application (2023-2028)
  • 7.3.3 Europe Toxicology Drug Screening Market Share by Application (2017-2028)
• 7.4 Europe Toxicology Drug Screening Market Size by Country
  • 7.4.1 Europe Toxicology Drug Screening Market Size by Country (2017-2022)
  • 7.4.2 Europe Toxicology Drug Screening Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Toxicology Drug Screening Market Size (2017-2028)
• 8.2 Asia-Pacific Toxicology Drug Screening Market Size by Type
  • 8.2.1 Asia-Pacific Toxicology Drug Screening Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Toxicology Drug Screening Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Toxicology Drug Screening Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Toxicology Drug Screening Market Size by Application
  • 8.3.1 Asia-Pacific Toxicology Drug Screening Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Toxicology Drug Screening Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Toxicology Drug Screening Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Toxicology Drug Screening Market Size by Region
  • 8.4.1 Asia-Pacific Toxicology Drug Screening Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Toxicology Drug Screening Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Toxicology Drug Screening Market Size (2017-2028)
• 9.2 Latin America Toxicology Drug Screening Market Size by Type
  • 9.2.1 Latin America Toxicology Drug Screening Market Size by Type (2017-2022)
  • 9.2.2 Latin America Toxicology Drug Screening Market Size by Type (2023-2028)
  • 9.2.3 Latin America Toxicology Drug Screening Market Share by Type (2017-2028)
• 9.3 Latin America Toxicology Drug Screening Market Size by Application
  • 9.3.1 Latin America Toxicology Drug Screening Market Size by Application (2017-2022)
  • 9.3.2 Latin America Toxicology Drug Screening Market Size by Application (2023-2028)
  • 9.3.3 Latin America Toxicology Drug Screening Market Share by Application (2017-2028)
• 9.4 Latin America Toxicology Drug Screening Market Size by Country
  • 9.4.1 Latin America Toxicology Drug Screening Market Size by Country (2017-2022)
  • 9.4.2 Latin America Toxicology Drug Screening Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Toxicology Drug Screening Market Size (2017-2028)
• 10.2 Middle East & Africa Toxicology Drug Screening Market Size by Type
  • 10.2.1 Middle East & Africa Toxicology Drug Screening Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Toxicology Drug Screening Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Toxicology Drug Screening Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Toxicology Drug Screening Market Size by Application
  • 10.3.1 Middle East & Africa Toxicology Drug Screening Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Toxicology Drug Screening Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Toxicology Drug Screening Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Toxicology Drug Screening Market Size by Country
  • 10.4.1 Middle East & Africa Toxicology Drug Screening Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Toxicology Drug Screening Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Thermo Fisher Scientific Inc.
  • 11.1.1 Thermo Fisher Scientific Inc. Company Details
  • 11.1.2 Thermo Fisher Scientific Inc. Business Overview
  • 11.1.3 Thermo Fisher Scientific Inc. Toxicology Drug Screening Introduction
  • 11.1.4 Thermo Fisher Scientific Inc. Revenue in Toxicology Drug Screening Business (2017-2022)
  • 11.1.5 Thermo Fisher Scientific Inc. Recent Developments
• 11.2 Merck
  • 11.2.1 Merck Company Details
  • 11.2.2 Merck Business Overview
  • 11.2.3 Merck Toxicology Drug Screening Introduction
  • 11.2.4 Merck Revenue in Toxicology Drug Screening Business (2017-2022)
  • 11.2.5 Merck Recent Developments
• 11.3 Bio-Rad Laboratories Inc.
  • 11.3.1 Bio-Rad Laboratories Inc. Company Details
  • 11.3.2 Bio-Rad Laboratories Inc. Business Overview
  • 11.3.3 Bio-Rad Laboratories Inc. Toxicology Drug Screening Introduction
  • 11.3.4 Bio-Rad Laboratories Inc. Revenue in Toxicology Drug Screening Business (2017-2022)
  • 11.3.5 Bio-Rad Laboratories Inc. Recent Developments
• 11.4 Danaher
  • 11.4.1 Danaher Company Details
  • 11.4.2 Danaher Business Overview
  • 11.4.3 Danaher Toxicology Drug Screening Introduction
  • 11.4.4 Danaher Revenue in Toxicology Drug Screening Business (2017-2022)
  • 11.4.5 Danaher Recent Developments
• 11.5 Charles River Laboratories International Inc.
  • 11.5.1 Charles River Laboratories International Inc. Company Details
  • 11.5.2 Charles River Laboratories International Inc. Business Overview
  • 11.5.3 Charles River Laboratories International Inc. Toxicology Drug Screening Introduction
  • 11.5.4 Charles River Laboratories International Inc. Revenue in Toxicology Drug Screening Business (2017-2022)
  • 11.5.5 Charles River Laboratories International Inc. Recent Developments
• 11.6 Enzo Life Sciences Inc.
  • 11.6.1 Enzo Life Sciences Inc. Company Details
  • 11.6.2 Enzo Life Sciences Inc. Business Overview
  • 11.6.3 Enzo Life Sciences Inc. Toxicology Drug Screening Introduction
  • 11.6.4 Enzo Life Sciences Inc. Revenue in Toxicology Drug Screening Business (2017-2022)
  • 11.6.5 Enzo Life Sciences Inc. Recent Developments
• 11.7 Eurofins Scientific
  • 11.7.1 Eurofins Scientific Company Details
  • 11.7.2 Eurofins Scientific Business Overview
  • 11.7.3 Eurofins Scientific Toxicology Drug Screening Introduction
  • 11.7.4 Eurofins Scientific Revenue in Toxicology Drug Screening Business (2017-2022)
  • 11.7.5 Eurofins Scientific Recent Developments
• 11.8 Selvita
  • 11.8.1 Selvita Company Details
  • 11.8.2 Selvita Business Overview
  • 11.8.3 Selvita Toxicology Drug Screening Introduction
  • 11.8.4 Selvita Revenue in Toxicology Drug Screening Business (2017-2022)
  • 11.8.5 Selvita Recent Developments
• 11.9 Laboratory Corporation of America Holdings
  • 11.9.1 Laboratory Corporation of America Holdings Company Details
  • 11.9.2 Laboratory Corporation of America Holdings Business Overview
  • 11.9.3 Laboratory Corporation of America Holdings Toxicology Drug Screening Introduction
  • 11.9.4 Laboratory Corporation of America Holdings Revenue in Toxicology Drug Screening Business (2017-2022)
  • 11.9.5 Laboratory Corporation of America Holdings Recent Developments
• 11.10 Promega Corporation
  • 11.10.1 Promega Corporation Company Details
  • 11.10.2 Promega Corporation Business Overview
  • 11.10.3 Promega Corporation Toxicology Drug Screening Introduction
  • 11.10.4 Promega Corporation Revenue in Toxicology Drug Screening Business (2017-2022)
  • 11.10.5 Promega Corporation Recent Developments
• 11.11 The Jackson Laboratory
  • 11.11.1 The Jackson Laboratory Company Details
  • 11.11.2 The Jackson Laboratory Business Overview
  • 11.11.3 The Jackson Laboratory Toxicology Drug Screening Introduction
  • 11.11.4 The Jackson Laboratory Revenue in Toxicology Drug Screening Business (2017-2022)
  • 11.11.5 The Jackson Laboratory Recent Developments
• 11.12 Agilent Technologies, Inc
  • 11.12.1 Agilent Technologies, Inc Company Details
  • 11.12.2 Agilent Technologies, Inc Business Overview
  • 11.12.3 Agilent Technologies, Inc Toxicology Drug Screening Introduction
  • 11.12.4 Agilent Technologies, Inc Revenue in Toxicology Drug Screening Business (2017-2022)
  • 11.12.5 Agilent Technologies, Inc Recent Developments
• 11.13 Waters
  • 11.13.1 Waters Company Details
  • 11.13.2 Waters Business Overview
  • 11.13.3 Waters Toxicology Drug Screening Introduction
  • 11.13.4 Waters Revenue in Toxicology Drug Screening Business (2017-2022)
  • 11.13.5 Waters Recent Developments
• 11.14 TECHCOMP GROUP
  • 11.14.1 TECHCOMP GROUP Company Details
  • 11.14.2 TECHCOMP GROUP Business Overview
  • 11.14.3 TECHCOMP GROUP Toxicology Drug Screening Introduction
  • 11.14.4 TECHCOMP GROUP Revenue in Toxicology Drug Screening Business (2017-2022)
  • 11.14.5 TECHCOMP GROUP Recent Developments
• 11.15 Wuxi AppTec
  • 11.15.1 Wuxi AppTec Company Details
  • 11.15.2 Wuxi AppTec Business Overview
  • 11.15.3 Wuxi AppTec Toxicology Drug Screening Introduction
  • 11.15.4 Wuxi AppTec Revenue in Toxicology Drug Screening Business (2017-2022)
  • 11.15.5 Wuxi AppTec Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Toxicology Drug Screening Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Cardiovascular Disease Drug Screening
• Table 3. Key Players of Obesity Drug Screening
• Table 4. Key Players of Diabetes Drug Screening
• Table 5. Key Players of Others
• Table 6. Global Toxicology Drug Screening Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 7. Global Toxicology Drug Screening Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 8. Global Toxicology Drug Screening Market Size by Region (2017-2022) & (US$ Million)
• Table 9. Global Toxicology Drug Screening Market Share by Region (2017-2022)
• Table 10. Global Toxicology Drug Screening Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 11. Global Toxicology Drug Screening Market Share by Region (2023-2028)
• Table 12. Toxicology Drug Screening Market Trends
• Table 13. Toxicology Drug Screening Market Drivers
• Table 14. Toxicology Drug Screening Market Challenges
• Table 15. Toxicology Drug Screening Market Restraints
• Table 16. Global Toxicology Drug Screening Revenue by Players (2017-2022) & (US$ Million)
• Table 17. Global Toxicology Drug Screening Revenue Share by Players (2017-2022)
• Table 18. Global Top Toxicology Drug Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Toxicology Drug Screening as of 2021)
• Table 19. Ranking of Global Top Toxicology Drug Screening Companies by Revenue (US$ Million) in 2021
• Table 20. Global 5 Largest Players Market Share by Toxicology Drug Screening Revenue (CR5 and HHI) & (2017-2022)
• Table 21. Key Players Headquarters and Area Served
• Table 22. Key Players Toxicology Drug Screening Product Solution and Service
• Table 23. Date of Enter into Toxicology Drug Screening Market
• Table 24. Mergers & Acquisitions, Expansion Plans
• Table 25. Global Toxicology Drug Screening Market Size by Type (2017-2022) & (US$ Million)
• Table 26. Global Toxicology Drug Screening Revenue Market Share by Type (2017-2022)
• Table 27. Global Toxicology Drug Screening Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 28. Global Toxicology Drug Screening Revenue Market Share by Type (2023-2028)
• Table 29. Global Toxicology Drug Screening Market Size by Application (2017-2022) & (US$ Million)
• Table 30. Global Toxicology Drug Screening Revenue Share by Application (2017-2022)
• Table 31. Global Toxicology Drug Screening Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 32. Global Toxicology Drug Screening Revenue Share by Application (2023-2028)
• Table 33. North America Toxicology Drug Screening Market Size by Type (2017-2022) & (US$ Million)
• Table 34. North America Toxicology Drug Screening Market Size by Type (2023-2028) & (US$ Million)
• Table 35. North America Toxicology Drug Screening Market Size by Application (2017-2022) & (US$ Million)
• Table 36. North America Toxicology Drug Screening Market Size by Application (2023-2028) & (US$ Million)
• Table 37. North America Toxicology Drug Screening Market Size by Country (2017-2022) & (US$ Million)
• Table 38. North America Toxicology Drug Screening Market Size by Country (2023-2028) & (US$ Million)
• Table 39. Europe Toxicology Drug Screening Market Size by Type (2017-2022) & (US$ Million)
• Table 40. Europe Toxicology Drug Screening Market Size by Type (2023-2028) & (US$ Million)
• Table 41. Europe Toxicology Drug Screening Market Size by Application (2017-2022) & (US$ Million)
• Table 42. Europe Toxicology Drug Screening Market Size by Application (2023-2028) & (US$ Million)
• Table 43. Europe Toxicology Drug Screening Market Size by Country (2017-2022) & (US$ Million)
• Table 44. Europe Toxicology Drug Screening Market Size by Country (2023-2028) & (US$ Million)
• Table 45. Asia Pacific Toxicology Drug Screening Market Size by Type (2017-2022) & (US$ Million)
• Table 46. Asia Pacific Toxicology Drug Screening Market Size by Type (2023-2028) & (US$ Million)
• Table 47. Asia Pacific Toxicology Drug Screening Market Size by Application (2017-2022) & (US$ Million)
• Table 48. Asia Pacific Toxicology Drug Screening Market Size by Application (2023-2028) & (US$ Million)
• Table 49. Asia Pacific Toxicology Drug Screening Market Size by Region (2017-2022) & (US$ Million)
• Table 50. Asia Pacific Toxicology Drug Screening Market Size by Region (2023-2028) & (US$ Million)
• Table 51. Latin America Toxicology Drug Screening Market Size by Type (2017-2022) & (US$ Million)
• Table 52. Latin America Toxicology Drug Screening Market Size by Type (2023-2028) & (US$ Million)
• Table 53. Latin America Toxicology Drug Screening Market Size by Application (2017-2022) & (US$ Million)
• Table 54. Latin America Toxicology Drug Screening Market Size by Application (2023-2028) & (US$ Million)
• Table 55. Latin America Toxicology Drug Screening Market Size by Country (2017-2022) & (US$ Million)
• Table 56. Latin America Toxicology Drug Screening Market Size by Country (2023-2028) & (US$ Million)
• Table 57. Middle East and Africa Toxicology Drug Screening Market Size by Type (2017-2022) & (US$ Million)
• Table 58. Middle East and Africa Toxicology Drug Screening Market Size by Type (2023-2028) & (US$ Million)
• Table 59. Middle East and Africa Toxicology Drug Screening Market Size by Application (2017-2022) & (US$ Million)
• Table 60. Middle East and Africa Toxicology Drug Screening Market Size by Application (2023-2028) & (US$ Million)
• Table 61. Middle East and Africa Toxicology Drug Screening Market Size by Country (2017-2022) & (US$ Million)
• Table 62. Middle East and Africa Toxicology Drug Screening Market Size by Country (2023-2028) & (US$ Million)
• Table 63. Thermo Fisher Scientific Inc. Company Details
• Table 64. Thermo Fisher Scientific Inc. Business Overview
• Table 65. Thermo Fisher Scientific Inc. Toxicology Drug Screening Product
• Table 66. Thermo Fisher Scientific Inc. Revenue in Toxicology Drug Screening Business (2017-2022) & (US$ Million)
• Table 67. Thermo Fisher Scientific Inc. Recent Developments
• Table 68. Merck Company Details
• Table 69. Merck Business Overview
• Table 70. Merck Toxicology Drug Screening Product
• Table 71. Merck Revenue in Toxicology Drug Screening Business (2017-2022) & (US$ Million)
• Table 72. Merck Recent Developments
• Table 73. Bio-Rad Laboratories Inc. Company Details
• Table 74. Bio-Rad Laboratories Inc. Business Overview
• Table 75. Bio-Rad Laboratories Inc. Toxicology Drug Screening Product
• Table 76. Bio-Rad Laboratories Inc. Revenue in Toxicology Drug Screening Business (2017-2022) & (US$ Million)
• Table 77. Bio-Rad Laboratories Inc. Recent Developments
• Table 78. Danaher Company Details
• Table 79. Danaher Business Overview
• Table 80. Danaher Toxicology Drug Screening Product
• Table 81. Danaher Revenue in Toxicology Drug Screening Business (2017-2022) & (US$ Million)
• Table 82. Danaher Recent Developments
• Table 83. Charles River Laboratories International Inc. Company Details
• Table 84. Charles River Laboratories International Inc. Business Overview
• Table 85. Charles River Laboratories International Inc. Toxicology Drug Screening Product
• Table 86. Charles River Laboratories International Inc. Revenue in Toxicology Drug Screening Business (2017-2022) & (US$ Million)
• Table 87. Charles River Laboratories International Inc. Recent Developments
• Table 88. Enzo Life Sciences Inc. Company Details
• Table 89. Enzo Life Sciences Inc. Business Overview
• Table 90. Enzo Life Sciences Inc. Toxicology Drug Screening Product
• Table 91. Enzo Life Sciences Inc. Revenue in Toxicology Drug Screening Business (2017-2022) & (US$ Million)
• Table 92. Enzo Life Sciences Inc. Recent Developments
• Table 93. Eurofins Scientific Company Details
• Table 94. Eurofins Scientific Business Overview
• Table 95. Eurofins Scientific Toxicology Drug Screening Product
• Table 96. Eurofins Scientific Revenue in Toxicology Drug Screening Business (2017-2022) & (US$ Million)
• Table 97. Eurofins Scientific Recent Developments
• Table 98. Selvita Company Details
• Table 99. Selvita Business Overview
• Table 100. Selvita Toxicology Drug Screening Product
• Table 101. Selvita Revenue in Toxicology Drug Screening Business (2017-2022) & (US$ Million)
• Table 102. Selvita Recent Developments
• Table 103. Laboratory Corporation of America Holdings Company Details
• Table 104. Laboratory Corporation of America Holdings Business Overview
• Table 105. Laboratory Corporation of America Holdings Toxicology Drug Screening Product
• Table 106. Laboratory Corporation of America Holdings Revenue in Toxicology Drug Screening Business (2017-2022) & (US$ Million)
• Table 107. Laboratory Corporation of America Holdings Recent Developments
• Table 108. Promega Corporation Company Details
• Table 109. Promega Corporation Business Overview
• Table 110. Promega Corporation Toxicology Drug Screening Product
• Table 111. Promega Corporation Revenue in Toxicology Drug Screening Business (2017-2022) & (US$ Million)
• Table 112. Promega Corporation Recent Developments
• Table 113. The Jackson Laboratory Company Details
• Table 114. The Jackson Laboratory Business Overview
• Table 115. The Jackson Laboratory Toxicology Drug Screening Product
• Table 116. The Jackson Laboratory Revenue in Toxicology Drug Screening Business (2017-2022) & (US$ Million)
• Table 117. The Jackson Laboratory Recent Developments
• Table 118. Agilent Technologies, Inc Company Details
• Table 119. Agilent Technologies, Inc Business Overview
• Table 120. Agilent Technologies, Inc Toxicology Drug Screening Product
• Table 121. Agilent Technologies, Inc Revenue in Toxicology Drug Screening Business (2017-2022) & (US$ Million)
• Table 122. Agilent Technologies, Inc Recent Developments
• Table 123. Waters Company Details
• Table 124. Waters Business Overview
• Table 125. Waters Toxicology Drug Screening Product
• Table 126. Waters Revenue in Toxicology Drug Screening Business (2017-2022) & (US$ Million)
• Table 127. Waters Recent Developments
• Table 128. TECHCOMP GROUP Company Details
• Table 129. TECHCOMP GROUP Business Overview
• Table 130. TECHCOMP GROUP Toxicology Drug Screening Product
• Table 131. TECHCOMP GROUP Revenue in Toxicology Drug Screening Business (2017-2022) & (US$ Million)
• Table 132. TECHCOMP GROUP Recent Developments
• Table 133. Wuxi AppTec Company Details
• Table 134. Wuxi AppTec Business Overview
• Table 135. Wuxi AppTec Toxicology Drug Screening Product
• Table 136. Wuxi AppTec Revenue in Toxicology Drug Screening Business (2017-2022) & (US$ Million)
• Table 137. Wuxi AppTec Recent Developments
• Table 138. Research Programs/Design for This Report
• Table 139. Key Data Information from Secondary Sources
• Table 140. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Toxicology Drug Screening Market Share by Type: 2021 VS 2028
• Figure 2. Cardiovascular Disease Drug Screening Features
• Figure 3. Obesity Drug Screening Features
• Figure 4. Diabetes Drug Screening Features
• Figure 5. Others Features
• Figure 6. Global Toxicology Drug Screening Market Share by Application: 2021 VS 2028
• Figure 7. Hospitals Case Studies
• Figure 8. Clinics Case Studies
• Figure 9. Laboratory Case Studies
• Figure 10. Others Case Studies
• Figure 11. Toxicology Drug Screening Report Years Considered
• Figure 12. Global Toxicology Drug Screening Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 13. Global Toxicology Drug Screening Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 14. Global Toxicology Drug Screening Market Share by Region: 2021 VS 2028
• Figure 15. Global Toxicology Drug Screening Market Share by Players in 2021
• Figure 16. Global Top Toxicology Drug Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Toxicology Drug Screening as of 2021)
• Figure 17. The Top 10 and 5 Players Market Share by Toxicology Drug Screening Revenue in 2021
• Figure 18. North America Toxicology Drug Screening Market Size YoY (2017-2028) & (US$ Million)
• Figure 19. North America Toxicology Drug Screening Market Size Market Share by Type (2017-2028)
• Figure 20. North America Toxicology Drug Screening Market Size Market Share by Application (2017-2028)
• Figure 21. North America Toxicology Drug Screening Market Size Share by Country (2017-2028)
• Figure 22. United States Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 23. Canada Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 24. Europe Toxicology Drug Screening Market Size YoY (2017-2028) & (US$ Million)
• Figure 25. Europe Toxicology Drug Screening Market Size Market Share by Type (2017-2028)
• Figure 26. Europe Toxicology Drug Screening Market Size Market Share by Application (2017-2028)
• Figure 27. Europe Toxicology Drug Screening Market Size Share by Country (2017-2028)
• Figure 28. Germany Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 29. France Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. U.K. Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. Italy Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. Russia Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 33. Nordic Countries Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 34. Asia-Pacific Toxicology Drug Screening Market Size YoY (2017-2028) & (US$ Million)
• Figure 35. Asia Pacific Toxicology Drug Screening Market Size Market Share by Type (2017-2028)
• Figure 36. Asia Pacific Toxicology Drug Screening Market Size Market Share by Application (2017-2028)
• Figure 37. Asia Pacific Toxicology Drug Screening Market Size Share by Region (2017-2028)
• Figure 38. China Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 39. Japan Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. South Korea Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 41. Southeast Asia Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 42. India Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 43. Australia Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 44. Latin America Toxicology Drug Screening Market Size YoY (2017-2028) & (US$ Million)
• Figure 45. Latin America Toxicology Drug Screening Market Size Market Share by Type (2017-2028)
• Figure 46. Latin America Toxicology Drug Screening Market Size Market Share by Application (2017-2028)
• Figure 47. Latin America Toxicology Drug Screening Market Size Share by Country (2017-2028)
• Figure 48. Mexico Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 49. Brazil Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 50. Middle East & Africa Toxicology Drug Screening Market Size YoY (2017-2028) & (US$ Million)
• Figure 51. Middle East and Africa Toxicology Drug Screening Market Size Market Share by Type (2017-2028)
• Figure 52. Middle East and Africa Toxicology Drug Screening Market Size Market Share by Application (2017-2028)
• Figure 53. Middle East and Africa Toxicology Drug Screening Market Size Share by Country (2017-2028)
• Figure 54. Turkey Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 55. Saudi Arabia Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 56. UAE Toxicology Drug Screening Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 57. Thermo Fisher Scientific Inc. Revenue Growth Rate in Toxicology Drug Screening Business (2017-2022)
• Figure 58. Merck Revenue Growth Rate in Toxicology Drug Screening Business (2017-2022)
• Figure 59. Bio-Rad Laboratories Inc. Revenue Growth Rate in Toxicology Drug Screening Business (2017-2022)
• Figure 60. Danaher Revenue Growth Rate in Toxicology Drug Screening Business (2017-2022)
• Figure 61. Charles River Laboratories International Inc. Revenue Growth Rate in Toxicology Drug Screening Business (2017-2022)
• Figure 62. Enzo Life Sciences Inc. Revenue Growth Rate in Toxicology Drug Screening Business (2017-2022)
• Figure 63. Eurofins Scientific Revenue Growth Rate in Toxicology Drug Screening Business (2017-2022)
• Figure 64. Selvita Revenue Growth Rate in Toxicology Drug Screening Business (2017-2022)
• Figure 65. Laboratory Corporation of America Holdings Revenue Growth Rate in Toxicology Drug Screening Business (2017-2022)
• Figure 66. Promega Corporation Revenue Growth Rate in Toxicology Drug Screening Business (2017-2022)
• Figure 67. The Jackson Laboratory Revenue Growth Rate in Toxicology Drug Screening Business (2017-2022)
• Figure 68. Agilent Technologies, Inc Revenue Growth Rate in Toxicology Drug Screening Business (2017-2022)
• Figure 69. Waters Revenue Growth Rate in Toxicology Drug Screening Business (2017-2022)
• Figure 70. TECHCOMP GROUP Revenue Growth Rate in Toxicology Drug Screening Business (2017-2022)
• Figure 71. Wuxi AppTec Revenue Growth Rate in Toxicology Drug Screening Business (2017-2022)
• Figure 72. Bottom-up and Top-down Approaches for This Report
• Figure 73. Data Triangulation
• Figure 74. Key Executives Interviewed